Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
biotech
boston
boston top stories
national top stories
new york blog main
san francisco blog main
clinical trials
financing
funding
new york top stories
san diego blog main
san francisco top stories
startups
accelerator
airbnb
akero therapeutics
aligos therapeutics
amazon web services (aws)
apellis pharmaceuticals
aragon pharmaceuticals
artificial intelligence (a.i.)
astellas pharma
athelas
atlas venture
atomwise
audentes therapeutics
avidity biosciences
baker brothers life sciences
benchling
benzodiazepine
biotech ipos
biotechnology
blackstone group
blepharitis
bluebird bio
cancer
cavion
What
biotechs
4
×
ago
ipos
medicines
admits
approach
bags
big
capital
central
classes
cns
combinator
companies
considering
data
diseases
disorder
drug
drugs
dug
dyne
early
emerged
expected
experimental
eyes
genetic
having
humans
incubator
investing
investors
ipo
kept
leads
led
life
limited
long
Language
unset
4
×
Current search:
biotechs
×
unset
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In